Group ACYW135 Meningococcal Polysaccharide Vaccine

Specification

• Cat#: VAC-0381
• Product Name: Group ACYW135 Meningococcal Polysaccharide Vaccine
• Description: This strain respectively in group A, group C, Y and W135 group of neisseria gonorrhoeae culture, extraction and purification, respectively, group A and group C, Y and W135 polysaccharide group of neisseria gonorrhoeae antigen, blend to join after lyophilization in the suitable stabilizer Used for prevention of group A, group C, Y and W135 group of neisseria gonorrhoeae epidemic cerebrospinal meningitis
• Storage: Store and transport from 2°C to 8°C out of light.
• Function: For the prevention of epidemic cerebrospinal meningitis caused by Neisseria meningitidis group A, group C, group Y and group W135.

Q&As (2)

Can you clarify if Group ACYW135 Meningococcal Polysaccharide Vaccine, catalog #VAC-0381 is purified polysaccharide? 5/1/2025

The Group ACYW135 Meningococcal Polysaccharide Vaccine (Catalog #VAC-0381) is indeed a purified polysaccharide. It is prepared from the purified capsular polysaccharides of Neisseria meningitidis groups A, C, Y, and W135. Each polysaccharide component is purified through a series of steps to ensure high purity and quality, suitable for research use.

Is this a lyophilized product? 5/1/2025

No, it's in liquid form.